Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study
Titel:
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study
Auteur:
Tacchetti, Paola Pantani, Lucia Patriarca, Francesca Petrucci, Maria Teresa Zamagni, Elena Dozza, Luca Galli, Monica Di Raimondo, Francesco Crippa, Claudia Boccadoro, Mario Barbato, Simona Tosi, Patrizia Narni, Franco Montefusco, Vittorio Testoni, Nicoletta Spadano, Antonio Terragna, Carolina Pescosta, Norbert Marzocchi, Giulia Cellini, Claudia Galieni, Piero Ronconi, Sonia Gobbi, Marco Catalano, Lucio Lazzaro, Antonio De Sabbata, Giovanni Cangialosi, Clotilde Ciambelli, Fabrizio Musto, Pellegrino Elice, Francesca Cavo, Michele